Contribution of autonomic neuropathy to reduced plasma adrenallne responses to hypoglycemia in IDDM: Evidence for a nonselective defect

Diabetes

Volumn 46, Issue 5, 1997, Pages 814-823

  Bottini, Paolo ^a   Boschetti, Enrico ^a   Pampanelli, Simone ^a   Ciofetta, Marco ^a   Del Sindaco, Paola ^a   Scionti, Luciano ^a   Brunetti, Paolo ^a   Bolli, Geremia B ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCOSE; INSULIN;

ADRENALIN BLOOD LEVEL; ADRENALIN RELEASE; ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL;

EID: 0030897350     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.5.814     Document Type: Article

References (55)

1. Reichard P, Nilsson BY, Rosenquist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Pampanelli S, Fanelli C, Lalli C, Ciofetta M, Del Sindaco P, Lepore M, Modarelli F, Rambotti AM, Epifano L, Di Vincenzo A, Bartocci L, Annibale B, Brunetti P, Bolli GB: Long-term intensive insulin therapy: effects of HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and unawareness of hypoglycaemia Diabetologia 39:677-686, 1996
4. Bolli GB, Dimitriadis GD, Pehling GB, Baker BA, Haymond MW, Cryer PE, Gerich JE: Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med 310:1706-1711, 1984
5. Bolli GB: From physiology of glucose counterregulation to prevention of hypoglycaemia in type 1 diabetes mellitus. Diabetes Nutr Metab 3:333-349, 1990
6. Gerich JE, Langlois M, Noacco C, Karam LH, Forsham PH: Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 182:171-173, 1973
7. Bolli GB, De Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich J: Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32:134-141, 1983
8. De Feo P, Perriello G, Torlone E, Fanelli C, Ventura MM, Santeusanio F, Brunetti P, Gerich JE, Bolli GB: Evidence against important catecholamine compensation for absent glucagon counterregulation. Am J Physiol 260:E203-E212, 1991
9. De Feo P, Perriello G, Torlone E, Fanelli C, Ventura MM, Santeusanio F, Brunetti P, Gerich JE, Bolli GB: The contribution of adrenergic mechanisms to glucose counterregulation in humans. Am J Physiol 261:E725-E736, 1991
10. Bolli G, De Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P: Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type 1 diabetes: evidence for an effect mediated by beta-adrenoreceptors. Diabetes 31:641-647, 1982
11. 2-adrenergic receptors. Diabetes 32:887-893, 1983
12. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feo P, Santeusanio F, Brunetti P, Bolli GB: Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of a rationale, intensive insulin therapy in IDDM. Diabetologia 37:1265-1276, 1994
13. White NH, Skor DA, Cryer PE, Bier DM, Levandoski L, Santiago JV: Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485-491, 1983
14. Bolli G, De Feo P, De Cosmo S, Perriello G, Ventura MM, Massi Benedetti M, Santeusanio F, Gerich JE, Brunetti P: A reliable and reproducible test for adequate glucose counterregulation in type 1 (insulin-dependent) diabetes mellitus. Diabetes 33:732-737, 1984
15. Fanelli C, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia (near-)normalizes magnitude and glycemic thresholds of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with IDDM of short duration. Diabetes 42:1683-1689, 1993
16. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA: Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283-287, 1994
17. Dagogo-Jack S, Rattarasarn C, Cryer PE: Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43:1426-1434, 1994
18. White NH, Gingerich RL, Levandoski LA, Cryer PE, Santiago JV: Plasma pancreatic polypeptide response to insulin-induced hypoglycemia as a marker for defective glucose counterregulation in insulin-dependent diabetes mellitus. Diabetes 34:870-875, 1985
19. Cryer PE: Banting Lecture: hypoglycemia: the limiting factor of the management of IDDM. Diabetes 43:1378-1389, 1994
20. Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 91:819-828, 1993
21. Horie H, Hanafusa T, Matsuyama T, Namba M, Nonaka K, Tarui S, Yamatodani A, Wada H: Decreased response of epinephrine and norepinephrine to insulin-induced hypoglycemia in diabetic autonomic neuropathy. Horm Metab Res 16:398-401, 1984
22. Webb SM, Fernandez Castaner M: Glucose counterregulation in diabetic autonomic neuropathy. Clin Physiol (Suppl. 5):66-71, 1985
23. Kennedy FP, Bolli GB, Go VL, Cryer PE, Gerich JE: The significance of impaired pancreatic polypeptide and epinephrine responses to hypoglycemia in patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 64:602-608, 1987
24. Hoeldtke RD, Boden G, Shuman CR, Owen OE: Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomie neuropathy. Ann Intern Med 96:459-462, 1982
25. Hepburn DA, MacLeod KM, Frier BM: Physiological, symptomatic and hormonal responses to acute hypoglycaemia in type 1 diabetic patients with autonomic neuropathy. Diabetic Med 10:940-949, 1993
26. Hilsted J, Madsbad S, Krarup T, Christensen NJ, Tronier B, Galbo H: Hormonal, metabolic, and cardiovascular responses to hypoglycemia in diabetic autonomic neuropathy. Diabetes 30:626-633, 1981
27. Ryder RE, Owens DR, Hayes TM, Ghatei MA, Bloom SR: Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. Br Med J 301:783-787, 1990
28. Huffman RP, Singer-Granick C, Drash AL, Becker DJ: Plasma catecholamine response to hypoglycemia in children and adolescents with IDDM. Diabetes Care 14:81-88, 1991
29. Hirsh BR, Shamoon H: Defective epinephrine and growth hormone responses in type 1 diabetes are stimulus specific. Diabetes 36:20-26, 1987
30. Rattarasarn C, Dagogo-Jack S, Zachwieja JJ, Cryer PE: Hypoglycemia-induced autonomie failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation. Diabetes 43:809-818, 1994
31. Ewing DJ, Clarke BF: Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916-918, 1982
32. Bellavere F, Bosello G, Fedele D, Cardone C, Ferri M: Diagnosis and management of diabetic autonomic neuropathy [Letter]. Br Med J 287:61, 1983
33. Porcellati F, Fanelli C, Bottini P, Epifano L, Rambotti AM, Lalli C, Pampanelli S, Scionti L, Santeusanio F, Brunetti P, Hilsted J, Bolli GB: Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic subjects with and without autonomic neuropathy. Diabetes 42:1055-1064, 1993
34. Bottini P, Tantucci C, Scionti L, Dottorini ML, Puxeddu E, Reboldi G, Bolli GB, Casucci G, Santeusanio F, Sorbini CA, Brunetti P: Cardiovascular response to exercise in diabetic patients: influence of autonomic neuropathy of different severity. Diabetologia 38:244-250, 1995
35. Lingefelser T, Buettner VW, Renn W, Tobis M, Teichmann R, Eggstein M, Jakober B: Recovery of hypoglycaemia-associated compromised cerebral function after a short interval of euglycaemia in insulin-dependent diabetic patients. Electroencephalogr Clin Neurophysiol 12:196-203, 1994
36. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, Di Vincenzo A, Annibale B, Lepore M, Lalli C, Del Sindaco P, Brunetti P, Bolli GB: Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 37:797-807, 1994
37. De Feo P, Perriello G, Ventura MM, Calcinaro F, Basta G, Lolli C, Cruciani C, Dell'Olio A, Santeusanio F, Brunetti P, Bolli GB: Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia 29:475-480, 1986
38. McGuire E, Helderman J, Tobin R, Andres R, Berman M: Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573, 1976
39. Schwartz N, Clutter W, Shah S, Cryer P: Glycemic thresholds for activation of glucose counterregulatory systems are higher than the thresholds for symptoms. J Clin Invest 79:777-781, 1987
40. Towler DA, Havlin CE, Craft S, Cryer PH: Mechanisms of awareness of hypoglycemia: perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 42:1791-1798, 1993
41. Fanelli C, De Feo P, Porcellati F, Perriello G, Torlone E, Santeusanio F, Brunetti P, Bolli GB: Adenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest 89:2005-2013, 1992
42. Kohn A, Annibale B, Suriano G, Seven C, Spinella S, Delle Fave G: Gastric acid and pancreatic polypeptide responses to modified sham feeding: indication of an increased basal vagal tone in a subgroup of duodenal ulcer patients. Gut 26:776-782, 1985
43. Perriello G, Torlone E, Di Santo S, Fanelli C, De Feo P, Santeusanio F, Brunetti P, Bolli GB: Effects of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with IDDM. Diabetologia 31:811-815, 1988
44. Maran A, Lomas J, Macdonald IA, Amiel SA: Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia 38:1412-1418, 1995
45. Zar J: Biostatistical Analysis. Englewood Cliffs, NJ, Prentice Hall, 1984
46. Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226, 1991
47. Widom B, Simonson DC: Intermittent hypoglycemia impairs glucose counterregulation. Diabetes 41:1597-1602, 1992
48. Lingenfelser T, Renn W, Sommerwerck U, Jung MF, Buettner UW, Zaiser-Kaschel H, Kaschel E, Eggstein M, Jakober B: Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients. Diabetes 42:610-618, 1992
49. Tantucci C, Bottini P, Dottorini M, Puxeddu E, Casucci G, Scionti L, Sorbini CA: Ventilatory response to exercise in diabetics with autonomic neuropathy. J Appl Phys 81:1378-1386, 1996
50. Cryer PE, Silverberg AB, Santiago JV, Shah SD: Plasma catecholamines in diabetes: the syndromes of hypoadrenergic and hyperadrenergic postural hypotension. Am J Med 64:407-416, 1978
51. Hoffman RP, Sinkey CA, Kienzle MG, Anderson EA: Muscle sympathetic nerve activity is reduced in IDDM before overt autonomic neuropathy. Diabetes 42:375-380, 1993
52. 123I]Iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Diabetes 44:543-549, 1995
53. Schnell O, Kirsch C-M, Stemplinger J, Haslbeck M, Standl E: Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia 38:1345-1352, 1995
54. Schwartz TW: Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 85:1411-1425, 1983
55. Bolli GB, Fanelli C: Unawareness of hypoglycemia. N Engl J Med 333:1771-1772, 1995